×
About 685 results

ALLMedicine™ Peutz-Jeghers Syndrome Center

Research & Reviews  251 results

Diagnosis and management of cancer risk in the gastrointestinal hamartomatous polyposis...
https://doi.org/10.1016/j.gie.2022.02.044
Gastrointestinal Endoscopy; Boland CR, Idos GE et. al.

Apr 30th, 2022 - The gastrointestinal hamartomatous polyposis syndromes are rare, autosomal dominant disorders associated with an increased risk of benign and malignant intestinal and extraintestinal tumors. They include Peutz-Jeghers syndrome, juvenile polyposis ...

Diagnosis and Management of Cancer Risk in the Gastrointestinal Hamartomatous Polyposis...
https://doi.org/10.1053/j.gastro.2022.02.021
Gastroenterology Boland CR, Idos GE et. al.

Apr 30th, 2022 - The gastrointestinal hamartomatous polyposis syndromes are rare, autosomal dominant disorders associated with an increased risk of benign and malignant intestinal and extraintestinal tumors. They include Peutz-Jeghers syndrome, juvenile polyposis ...

Diagnosis and Management of Cancer Risk in the Gastrointestinal Hamartomatous Polyposis...
https://doi.org/10.14309/ajg.0000000000001755
The American Journal of Gastroenterology; Boland CR, Idos GE et. al.

Apr 27th, 2022 - The gastrointestinal hamartomatous polyposis syndromes are rare, autosomal dominant disorders associated with an increased risk of benign and malignant intestinal and extraintestinal tumors. They include Peutz-Jeghers syndrome, juvenile polyposis ...

Gastric-phenotype Mucinous Carcinoma of the Fallopian Tube with Secondary Ovarian Invol...
https://doi.org/10.1177/10668969221095264
International Journal of Surgical Pathology; Bronte Anaut M, Arredondo Montero J et. al.

Apr 26th, 2022 - Peutz-Jeghers syndrome is an autosomal dominant condition characterized by the association of hamartomatous polyps in the digestive tract, mucocutaneous pigmentation, family history, and infrequently tumors of the female genital tract with one of ...

Artificial Intelligence-assisted Colonoscopy on Detection of Missed Proximal Lesions
https://clinicaltrials.gov/ct2/show/NCT04294355

Apr 21st, 2022 - Centers Queen Mary Hospital, Hong Kong, China (Co-ordinating Center) Tan Tock Seng Hospital, Singapore, Singapore Institute of Gastroenterology and Hepatology, Vietnam Union of Science and Technology Association, Hanoi, Vietnam Study population In...

see more →

Guidelines  4 results

Diagnosis and management of cancer risk in the gastrointestinal hamartomatous polyposis...
https://doi.org/10.1016/j.gie.2022.02.044
Gastrointestinal Endoscopy; Boland CR, Idos GE et. al.

Apr 30th, 2022 - The gastrointestinal hamartomatous polyposis syndromes are rare, autosomal dominant disorders associated with an increased risk of benign and malignant intestinal and extraintestinal tumors. They include Peutz-Jeghers syndrome, juvenile polyposis ...

Diagnosis and Management of Cancer Risk in the Gastrointestinal Hamartomatous Polyposis...
https://doi.org/10.1053/j.gastro.2022.02.021
Gastroenterology Boland CR, Idos GE et. al.

Apr 30th, 2022 - The gastrointestinal hamartomatous polyposis syndromes are rare, autosomal dominant disorders associated with an increased risk of benign and malignant intestinal and extraintestinal tumors. They include Peutz-Jeghers syndrome, juvenile polyposis ...

Hereditary Cancer Syndromes and Risk Assessment: ACOG COMMITTEE OPINION, Number 793.
https://doi.org/10.1097/AOG.0000000000003562
Obstetrics and Gynecology;

Nov 26th, 2019 - A hereditary cancer syndrome is a genetic predisposition to certain types of cancer, often with onset at an early age, caused by inherited pathogenic variants in one or more genes. Most hereditary cancer syndromes exhibit autosomal dominant inheri...

ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal c...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695986
The American Journal of Gastroenterology; Syngal S, Brand RE et. al.

Feb 4th, 2015 - This guideline presents recommendations for the management of patients with hereditary gastrointestinal cancer syndromes. The initial assessment is the collection of a family history of cancers and premalignant gastrointestinal conditions and shou...

see more →

Clinicaltrials.gov  3 results

Artificial Intelligence-assisted Colonoscopy on Detection of Missed Proximal Lesions
https://clinicaltrials.gov/ct2/show/NCT04294355

Apr 21st, 2022 - Centers Queen Mary Hospital, Hong Kong, China (Co-ordinating Center) Tan Tock Seng Hospital, Singapore, Singapore Institute of Gastroenterology and Hepatology, Vietnam Union of Science and Technology Association, Hanoi, Vietnam Study population In...

Cancer of the Pancreas Screening Study (CAPS 3)
https://clinicaltrials.gov/ct2/show/NCT00438906

Jun 18th, 2021 - Pancreatic cancer (PC) is the 4th leading cause of cancer death in the U.S. Because it is seldom diagnosed at an early curable stage, nearly all patients die from their disease. Early detection of PC and its precursors will save lives. In a multi-...

Study of Everolimus in the Treatment of Advanced Malignancies in Patients With Peutz-Jeghers Syndrome
https://clinicaltrials.gov/ct2/show/NCT01178151

Apr 22nd, 2015 - In this pilot study the investigators will treat all patients known with Peutz-Jeghers syndrome (PJS) who are diagnosed with advanced malignancies with everolimus 10mg daily until disease progression. Most patients with PJS have an inherited LKB1 ...

see more →

News  13 results

New Guideline Sheds Light on Diagnosis, Treatment of Rare GI Syndromes
https://www.medscape.com/viewarticle/972971

Apr 29th, 2022 - A clinical practice guideline for the diagnosis and management of gastrointestinal hamartomatous polyposis syndromes has just been published by the U.S. Multi-Society Task Force on Colorectal Cancer, which is comprised of experts representing the ...

Pancreatic Cancer Surveillance in People at High Risk Not Tied to Better Outcomes
https://www.medscape.com/viewarticle/949359

Apr 16th, 2021 - NEW YORK (Reuters Health) - Surveillance of people at high hereditary risk for pancreatic ductal adenocarcinoma (PDAC) can lead to diagnosis at an earlier stage, but as yet there is no clear survival benefit, according to researchers in the Nether...

Advances in Small Bowel Cancer Generate New NCCN Guidelines
https://www.onclive.com/view/advances-in-small-bowel-cancer-generate-new-nccn-guidelines

Dec 5th, 2020 - Katrina S. Pedersen, MD, MS A new set of recommendations for the treatment of small bowel adenocarcinoma (SBA), a relatively rare type cancer of the gastrointestinal (GI) tract, have been created by the National Comprehensive Cancer Network (NCCN...

Expert Outlines Clinical Implications of Precision Medicine in GI Cancers
https://www.onclive.com/view/expert-outlines-clinical-implications-of-precision-medicine-in-gi-cancers

Dec 4th, 2020 - Shirley Michelle Shiller, DO Regarding precision medicine in gastrointestinal (GI) cancers, pathologists are working to determine which patient populations should undergo which molecular tests. Colorectal Cancer In a presentation during the 201...

AGA clinical practice update: Pancreatic cancer screening
https://www.mdedge.com/internalmedicine/article/223652/gastroenterology/aga-clinical-practice-update-pancreatic-cancer
Richard Mark Kirkner

Jun 10th, 2020 - Individuals at high risk for pancreatic cancer should at least be considered for screening for the disease, states a new clinical practice update from the American Gastroenterological Association that further defines what constitutes high risk for.

see more →

Patient Education  3 results see all →